Edwards Lifesciences Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows how much money Edwards made and spent in the second quarter, helping investors track the company's progress.
Announces the company's earnings for the second quarter, revealing whether Edwards is growing or struggling.
Allows Edwards to offer more stock awards to employees; more shares available may dilute existing owners' stakes.
Provides Edwards' earnings and financial position for the first quarter, essential for tracking company performance.
New CFO brings healthcare banking expertise; earns $925,000 salary plus $2.01 million sign-on bonus and $8 million in stock.
Discloses first quarter earnings showing whether the company is meeting investor expectations.
Comprehensive yearly report shows total earnings, assets, and risks; essential for assessing Edwards' overall health.
Stocky reads Edwards Lifesciences Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Edwards Lifesciences Corporation's most recent tracked filing was a 10-Q on 4 Aug 2026: Q2 2026 quarterly financial results filed.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.